SecBot SecBot

SENS

Senseonics Holdings, Inc.
Nasdaq· Industrial Instruments For Measurement, Display, and Control· Inc. DE· CIK 0001616543 Industrials & Manufacturing
$7.51 +0.11 (+1.49%)
Oct 23 4:00 PM ET · prev $7.40
Market cap
$391.3M
Small cap
Consensus
Buy
69% Buy or better · 13 analysts
Median target
$14.50
+93% · range $9.00–18.00
Next earnings
Nov 9
in 14 days · EPS est. −$0.52
1 year
+0.9%
from $7.44 · Oct 27
30 days
−23.7%
from $9.84
52-week range
$4.86–10.34
−27% from high · low Jul 22
Avg volume 20D
594.9K
shares / day
Short interest
🔒 Subscribers only
Insider net
+$351.2K
2 buyers · 0 sellers · since Mar 13
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·Next Earnings date, Nov 9, 2026
Strongest🔒 Fresh report (last 24h), subscribers only
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $351.2K at an average $6.52. No open-market sales. Price is 15% above their cost.

  • InstitutionsBULLISH

    Q2 2026: 21 added (0 new), 7 trimmed or exited.

  • AnalystsBULLISH

    9 of 13 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.602 → −$0.522 over 90 days. 2 up, 0 down in 30 days.

  • TrendDOWNTREND

    18% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.DOUBLED2,793,558$15.9M
UBS Group AGDOUBLED1,487,429$8.4M
GEODE CAPITAL MANAGEMENT, LLCDOUBLED1,132,210$6.4M
STATE STREET CORPDOUBLED511,117$2.9M
BANK OF AMERICA CORP /DE/DOUBLED394,465$2.2M
CHARLES SCHWAB INVESTMENT MANAGEMENT INCADD393,211$2.2M
NORTHERN TRUST CORPDOUBLED332,266$1.9M
VANGUARD FIDUCIARY TRUST COADD331,353$1.9M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts
Buy 69% rate it Buy or better
Strong Buy2Buy7Hold3Sell1Strong Sell0
12-month targets · 6 analysts

Price is below the lowest target. Median implies +93%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Oct 7, 2026Barclays
INITIATE
INITIATEEqual-Weight
Jul 15, 2026Mizuho
MAINTAIN
MAINTAINOutperform
May 12, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
May 11, 2026Stifel
MAINTAIN
MAINTAINHold

Insider ledger

Form 4
$351.2K
bought · 2 insiders
$0
sold · 0 insiders
+15.2%
vs their $6.52 cost
DateInsiderTypeValue
Oct 1, 2026
Steven Edelman
Director
AWARD$12.9K
Oct 1, 2026
ROEDER DOUGLAS A
Director
AWARD$14.7K
Oct 1, 2026
Fiorentino Edward
Director
AWARD$14.1K
Oct 1, 2026
Prince Douglas S
Director
AWARD$8.1K
Aug 19, 2026
ROEDER DOUGLAS A
Director
BUY$125.3K
Jul 1, 2026
Fiorentino Edward
Director
AWARD$14.1K
Jul 1, 2026
Prince Douglas S
Director
AWARD$8.1K
Jul 1, 2026
Steven Edelman
Director
AWARD$12.9K

Earnings setup

Estimates
Nov 9
reports in 14 days
−$0.52
EPS estimate, this quarter
+13%
estimate change, 90 days
2↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.52-$0.64–-$0.41+1.8%$16.2M
Next Q-$0.46-$0.56–-$0.39-0.3%$21.8M
Current FY-$2.29-$2.52–-$2.08+0.3%$64.2M
Next FY-$1.95-$2.15–-$1.67-0.4%$100.0M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 Press
🔒 Fresh report (last 24h), subscribers only
Oct 26, 2026 FDA
🔒 Fresh data, subscribers only
Oct 1, 2026 Insider
Steven Edelman was granted 1,292 shares
Director @ $9.96 ($12.9K)
Oct 1, 2026 Insider
ROEDER DOUGLAS A was granted 1,480 shares
Director @ $9.96 ($14.7K)
Oct 1, 2026 Insider
Fiorentino Edward was granted 1,418 shares
Director @ $9.96 ($14.1K)
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
2,793,558 shares ($15.9M)
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
1,487,429 shares ($8.4M)
Jun 6, 2026 Press
Senseonics presented positive real-world data at ADA 2026 showing Eversense 365 CGM delivers strong glucometrics and…
Impact 4/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 9, 2026
Earnings date
SENS Q3 2026 Earnings Scheduled — 2026-11-09
Recent
Oct 26, 2026
FDA
🔒 Fresh data, subscribers only
Oct 22, 2026
Press release
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
GERMANTOWN, Md., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development…
Aug 6, 2026
Earnings date
SENS Q2 2026 Earnings Scheduled — 2026-08-06
Jul 15, 2026
Short interest
Short Interest: SENS up 11% to 6.4M shares
Settlement 2026-07-15 | Days to cover: 10.24 | ≈15.35% of shares outstanding (est.)
Jun 30, 2026
Short interest
Short Interest: SENS up 20% to 5.8M shares
Settlement 2026-06-30 | Days to cover: 4.91 | ≈13.84% of shares outstanding (est.)

SecBot reports

5 filings · 4 press releases · 2 bullish · 2 bearish · 1 neutral
All SENS filing & press-release reports (9)